KeyBanc analyst Matthew Mishan reiterated an Overweight rating and $87.00 price target on Baxter International (NYSE: BAX).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments

Stifel Reiterates Buy Rating on Baxter International (BAX)July 28, 2022 9:57 AM Evercore ISI on Baxter International (BAX) Guidance Update: 'we think the magnitude of the cut was a surprise'July 28, 2022 9:55 AM Pre-Open Movers: Meta, Qualcomm Fall; Renewable Stocks Up on Schumer/Manchin DealJuly 28, 2022 9:12 AM Baxter (BAX) Reports In-Line Q2 EPSJuly 28, 2022 7:25 AM Form 10-Q BAXTER INTERNATIONAL For: Jun 30July 28, 2022 7:22 AM Form 8-K BAXTER INTERNATIONAL For: Jul 28July 28, 2022 7:20 AM Baxter Reports Second-Quarter 2022 ResultsJuly 28, 2022 7:15 AM Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic EffortsJuly 27, 2022 2:31 PM Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSAJuly 26, 2022 7:00 AM